Cat. #152695
Anti-Melanoma [LHM3]
Cat. #: 152695
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Melanoma
Class: Monoclonal
Application: IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Nick Tidman
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Melanoma [LHM3]
- Cancers detailed: Broadly Applicable
- Research fields: Cancer;Cell biology
- Clone: LHM3
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 120 kDa
- Reactivity: Human
- Host: Mouse
- Application: IHC ; IF ; IP ; WB
- Description: LHM3 can be used in a diagnostic panel for immunopathology of malignant melanoma. Potential candidate for immunoimaging and immunotherapy of disseminated melanoma.
- Immunogen: A 375P cell extract
- Isotype: IgG1 kappa
Target Details
- Target: Melanoma
- Molecular weight: 120 kDa
- Target background: LHM3 can be used in a diagnostic panel for immunopathology of malignant melanoma. Potential candidate for immunoimaging and immunotherapy of disseminated melanoma.
Applications
- Application: IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Kupsch et al. 1995. Melanoma Res. 5(6):403-11. PMID: 8589614.
- Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
